Caribou Biosciences's market cap is currently $262.61M. The company's EPS TTM is $-0.35; its P/E ratio is ―; Caribou Biosciences is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
